SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Beam Therapeutics Inc. (BEAM) (CIK 0001745999) (BEAM) — Feb 3, 2020

Beam Therapeutics Inc. (BEAM) (CIK 0001745999)
Date: Feb. 3, 2020 · CIK: 0001745999 · Accession: 0001193125-20-022634

AI Filing Summary & Sentiment

File numbers found in text: 333-233985

Date
February 3, 2020
Author
Not clearly detected
Form
CORRESP
Company
Beam Therapeutics Inc. (BEAM) (CIK 0001745999)

Letter

Company Acceleration Request

BEAM THERAPEUTICS INC.

26 Landsdowne Street

Cambridge, Massachusetts 02139

February 3, 2020

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:

Tonya Aldave

Re:

Beam Therapeutics Inc.

Registration Statement on Form S-1 (File No. 333-233985)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Beam Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 5, 2020, or as soon as possible thereafter. The Company hereby authorizes Marc Rubenstein or Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.

[Signature page follows]

Very truly yours,
BEAM THERAPEUTICS INC.

Show Raw Text
CORRESP
1
filename1.htm

Company Acceleration Request

 BEAM THERAPEUTICS INC.

26 Landsdowne Street

 Cambridge,
Massachusetts 02139

 February 3, 2020

 VIA EDGAR

 Securities and Exchange Commission

 Division of
Corporate Finance

 100 F Street, N.E.

 Washington, D.C. 20549

Attention:

Tonya Aldave

Re:

Beam Therapeutics Inc.

Registration Statement on Form S-1 (File No. 333-233985)

Request for Acceleration

 Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Beam Therapeutics Inc., a Delaware corporation (the “Company”),
hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 5, 2020, or as soon as possible thereafter. The Company hereby
authorizes Marc Rubenstein or Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961
as soon as the registration statement has been declared effective.

 [Signature page follows]

Very truly yours,

BEAM THERAPEUTICS INC.

By:

/s/ John Evans

Name:

John Evans

Title:

Chief Executive Officer

 Signature Page to Acceleration Request